Nonsteroidal anti-inflammatory drug-induced experimental gastropathy: Is gastric acid the major trigger?

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 7, 2010, Pages 651-653

  Brzozowski, Thomas ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3 FLUOROPHENYL) 5,5 DIMETHYL 4 (4 METHYLSULFONYLPHENYL) 2(5H) FURANONE; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; IBUPROFEN; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA;

DRUG INDUCED DISEASE; NONHUMAN; NOTE; PATHOPHYSIOLOGY; STOMACH ACID SECRETION; STOMACH MUCOSA INJURY; STOMACH ULCER; ULCEROGENESIS; CHEMICALLY INDUCED; HUMAN; STOMACH ACID;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GASTRIC ACID; HUMANS; STOMACH ULCER;

EID: 77953869069     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2010.05392.x     Document Type: Note

References (29)

1. Zinkievich J, George S, Jha S, Nandi J, Levine RA. Gastric acid is the key modulator in the pathogenesis of NSAID-induced ulceration in rats. Clin. Exp. Pharmacol. Physiol. 2010 37: 654 661.
2. Goldstein JL, Miner PB, Schlesinger PK, Liu S, Silberg DG. Intragastric control in non-steroidal anti-inflammatory drug users: Comparison of esomeprazole, lansoprazole and pantoprazole. Aliment. Pharmacol. Ther. 2006 23: 1189 1196.
3. Douthwaite AH, Lintott SAM. Gastroscopic observation of the effect of aspirin and certain other substances on the stomach. Lancet 1938 2: 1222 1225.
4. Talley NJ. Chronic peptic ulceration and non-steroidal anti-inflammatory drugs: More to be said about NSAIDs? Gastroenterology 1992 102: 1074 1078.
5. Hawkey CJ. Gastroduodenal problems associated with non-steroidal anti-inflammatory drugs. Scand. J. Gastroenterol. 1993 28 (Suppl. 94 5.
6. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years. Gastroenterology 1997 112: 1000 1016.
7. Renna NF, Vasquez MA, Lama MC, Gonzales ES, Miatello RM. Effect of chronic aspirin administration on experimental model of metabolic syndrome. Clin. Exp. Pharmacol. Physiol. 2009 36: 162 168.
8. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature 1971 231: 232 235.
9. Konturek SJ, Piastucki I, Brzozowski T et al. Role of prostaglandins in the formation of aspirin-induced gastric ulcers. Gastroenterology 1981 80: 4 9.
10. Pihan G, Rogers C, Szabo S. Vascular injury in acute gastric mucosal damage: Mediatory role of leukotrienes. Dig. Dis. Sci. 1998 33: 625 632.
11. Asako H, Kubes P, Wallace JL, Woy RE, Granger DN. Modulation of leucocyte adhesion in rat mesenteric venules by aspirin and salicylate. Gastroenterology 1992 103: 146 152.
12. Brzozowski T, Konturek PC, Pajdo R et al. Physiological mediators in non-steroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defence and adaptation. Focus on nitric oxide and lipoxins. J. Physiol. Pharmacol. 2008 59 (Suppl. 2 89 102.
13. Andrews FJ, Malcontenti-Wilson CO, Brien PE. Expression of adhesion molecules and leucocyte recruitment into gastric mucosa following ischaemia-reperfusion. Dig. Dis. Sci. 1997 42: 326 329.
14. Santucci L, Fiorucci S, Giansaqnti M et al. Pentoxyfilline prevents indomethacin-induced acute gastric mucosal damage in rats: Role of tumour necrosis factor alpha. Gut 1994 35: 909 915.
15. Appleyard CB, McCafferty DM, Tigley AW, Swain MG, Wallace JL. Tumor necrosis factor mediation of NSAID-induced gastric damage: Role of leucocyte adherence. Am. J. Physiol. 1996 270: G42 8.
16. Schwartzel EH Jr., Levine RA, Schwartz SE, Ganley CE. Indomethacin enhances histamine-stimulated acid production in rabbit isolated fundic glands. Prostaglandins Leukot. Med. 1984 14: 383 390.
17. Levine RA, Schwartzel EH. Effect of indomethacin on basal and histamine stimulated human gastric acid secretion. Gut 1984 25: 718 722.
18. Levine RA, Petokas S, Nandi J, Enthoven D. Effects of non-steroidal, antiinflammatory drugs on gastrointestinal injury and prostanoid generation in healthy volunteers. Dig. Dis. Sci. 1988 33: 660 666.
19. +-ATPase expression and activation in rabbit parietal cells. Clin. Exp. Pharmacol. Physiol. 2009 36: 127 134.
20. Tarnawski AS, Caves TC. Aspirin in the XXI century. Its major clinical impact, novel mechanisms of action and new safer formulations. Gastroenterology 2004 127: 341 343.
21. Vane JR, Bakhle S, Botting RM. Cyclooxygenase 1 and 2. Annu. Rev. Pharmacol. Toxicol. 1998 38: 97 120.
22. Brzozowski T, Konturek PC, Konturek SJ. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers. Microsc. Res. Techn. 2001 53: 343 353.
23. Langenbach R, Morhan SG, Tiano HF et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1995 83: 483 492.
24. Wallace JL, McKnight W, Reuter BK, Vergnolle N. NSAID-induced gastric damage in rats. Requirement for the inhibition of both cyclooxygenase 1 and 2. Gastroenterology 2000 119: 706 714.
25. Vane JR, Mitchell JA, Appleton I et al. Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc. Natl Acad. Sci. USA 1994 91: 2046 2050. (Pubitemid 24092039)
26. + secretion by non-steroidal anti-inflammatory drugs. J. Pharmacol. Exp. Ther. 1994 269: 932 940.
27. Barnett K, Bell CJ, McKnight W, Dicay M, Sharkey KA, Wallace JL. Role of cyclooxygenase-2 in modulating gastric acid secretion in the normal and inflamed rat stomach. Am. J. Physiol. Gastrointest. Liver Physiol. 2000 279: G7747 83.
28. Brzozowski T, Konturek PC, Konturek SJ et al. Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischaemia-reperfusion-induced gastric lesions. Eur. J. Pharmacol. 1999 385: 47 61.
29. Schmassman A, Peskar B, Stettler C et al. Effect of inhibition of prostaglandin endoperoxide synthase 2 in chronic gastrointestinal ulcer models in rats. Br. J. Pharmacol. 1998 123: 795 804.